Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multiplex Screen of Serum Biomarkers in Facioscapulohumeral Muscular Dystrophy

1 Jan 2014

Abstract excerpt

BACKGROUND: Recent studies have proposed a unified genetic model for Facioscapulohumeral muscular dystrophy (FSHD), identifying potential therapeutic targets for future clinical trials. Serum biomarkers related to disease activity will be important for proof of concept or early phase clinical studies. OBJECTIVE: To identify potential serum biomarkers in FSHD for possible use in future clinical trials. METHODS: We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiomyopathy and Myosin Studies
Share to Muscle Physiology and Disorders

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 25705588
DOI: 10.3233/jnd-140034

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multiplex Screen of Serum Biomarkers in Facioscapulohumeral Muscular DystrophyPMID 25705588Read ↗

Proteomics of Muscle Microdialysates Identifies Potential Circulating Biomarkers in Facioscapulohumeral Muscular DystrophySemantic proximity Read ↗

Multi-Omics Identifies Circulating miRNA and Protein Biomarkers for Facioscapulohumeral DystrophySemantic proximity Read ↗

A cross sectional study of two independent cohorts identifies serum biomarkers for facioscapulohumeral muscular dystrophy (FSHD)Semantic proximity Read ↗

Best practice guidelines on genetic diagnostics of facioscapulohumeral muscular dystrophy: Update of the 2012 guidelinesSemantic proximity Read ↗

A Targeted Approach for Evaluating DUX4-Regulated Proteins as Potential Serum Biomarkers for Facioscapulohumeral Muscular Dystrophy Using Immunoassay ProteomicsSemantic proximity Read ↗

Facioscapulohumeral muscular dystrophy (FSHD) molecular diagnosis: from traditional technology to the NGS eraSemantic proximity Read ↗

CLIA Laboratory Testing for Facioscapulohumeral Dystrophy: A Retrospective Analysis.Semantic proximity Read ↗

Single-molecule optical mapping enables accurate molecular diagnosis of facioscapulohumeral muscular dystrophy (FSHD)Semantic proximity Read ↗

Leveraging AI for facioscapulohumeral muscular dystrophy prediction and omics biomarker identificationSemantic proximity Read ↗

Elevated plasma complement components in facioscapulohumeral dystrophySemantic proximity Read ↗

Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis. FSH Consortium.Semantic proximity Read ↗

Facioscapulohumeral dystrophy weakened sarcomeric contractility is mimicked in induced pluripotent stem cells‐derived innervated muscle fibresSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.